Longitudinal Imaging of Liver Cancer Using MicroCT and Nanoparticle Contrast Agents in CRISPR/Cas9-Induced Liver Cancer Mouse Model
Introduction: Micro-computed tomography with nanoparticle contrast agents may be a suitable tool for monitoring the time course of the development and progression of tumors. Here, we suggest a practical and convenient experimental method for generating and longitudinally imaging murine liver cancer...
Հիմնական հեղինակներ: | Sang Bu An, Kwangmo Yang MD, PhD, Chang Won Kim MD, PhD, Si Ho Choi PhD, Eunji Kim, Sung Dae Kim, Jae Soo Koh |
---|---|
Ձևաչափ: | Հոդված |
Լեզու: | English |
Հրապարակվել է: |
SAGE Publishing
2021-05-01
|
Շարք: | Technology in Cancer Research & Treatment |
Առցանց հասանելիություն: | https://doi.org/10.1177/15330338211016466 |
Նմանատիպ նյութեր
-
Evaluation of Radiation Sensitivity Differences in Mouse Liver Tumor Organoids Using CRISPR/Cas9-Mediated Gene Mutation
: Wan Jeon MD, և այլն
Հրապարակվել է: (2023-03-01) -
The Application of the CRISPR/Cas9 System in the Treatment of Hepatitis B Liver Cancer
: Wei Lv MSc, և այլն
Հրապարակվել է: (2021-09-01) -
Added Value of Liver MRI in Patients Eligible for Surgical Resection or Ablation of Colorectal Liver Metastases Based on CT: A Systematic Review and Meta-Analysis
: Burak Görgec, MD, և այլն
Հրապարակվել է: (2024-03-01) -
Cancer of the Liver and its Relationship with Diabetes mellitus
: Sunday Amos Onikanni PhD, և այլն
Հրապարակվել է: (2022-12-01) -
GPSM2 Serves as an Independent Prognostic Biomarker for Liver Cancer Survival
: Dingquan Yang PhD, և այլն
Հրապարակվել է: (2020-08-01)